Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zhibitai Capsules vs Atorvastatin in Type 2 Diabetes with Dyslipidemia
ChiCTR2500109105Phase 4Not yet recruiting
- Sponsor
- Shuguang Hospital
- Start
- Sep 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of zhibitai in type 2 diabetes mellitus (T2DM) and dyslipidemia (2 arms), sponsored by Shuguang Hospital. Primary endpoint: Low-density lipoprotein cholesterol. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
zhibitai
03
Conditions
type 2 diabetes mellitus (T2DM)dyslipidemia
Beyond the preview
Go deeper on ChiCTR2500109105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109105.